{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:32:01Z","timestamp":1790152321575,"version":"4.0.1"},"reference-count":152,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Toxicology"],"published-print":{"date-parts":[[2021,9,14]]},"DOI":"10.1080\/10408444.2021.2008867","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:45:03Z","timestamp":1645098303000},"page":"695-722","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["A broader view on deriving a reference dose for THC traces in foods"],"prefix":"10.1080","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-6681","authenticated-orcid":false,"given":"Bernhard","family":"Beitzke","sequence":"first","affiliation":[{"name":"EIHA Advisory Committee, European Industrial Hemp Association, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Pate","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute, Western Sydney University, Westmead, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"CIT0001","unstructured":"Abbott Laboratories Ltd, Quebec, Canada. 2011. Marinol\u00ae product monograph. 01.01.2011. https:\/\/pdf.hres.ca\/dpd_pm\/00013378.PDF"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.06.053"},{"key":"CIT0003","volume-title":"Marijuana: the first twelve thousand years","author":"Abel EL.","year":"1980"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-015-1479-8"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/BF02085029"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3889-y"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.06.007"},{"issue":"5","key":"CIT0008","first-page":"322","volume":"52","author":"Auw\u00e4rter V","year":"2015","journal-title":"Blutalkohol"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3387-5"},{"key":"CIT0011","unstructured":"[BAG] Bundesamt f\u00fcr Gesundheitswesen [Federal Office of Public Health] (Switzerland). 1996. Lebensmittel-Info: Verwendung von Hanf in Lebensmitteln und Gebrauchsgegenst\u00e4nden [Food notes: Use of hemp in foods and objects of utility]. Bulletin 24, 24.6.1996, Kreisschreiben Nr. 2, 13.3.1996."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2010.11.013"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419881498"},{"key":"CIT0014","unstructured":"[BASt] Bundesanstalt f\u00fcr Stra\u00dfenwesen [Federal Highway Research Institute, Germany]. 2012. DRUID Final Report Deliverable 0.1.8 Rev 2.0. Authors: Schulze H, Schumacher M, Urmeew R, Auerbach K. https:\/\/www.bast.de\/Druid\/EN\/Dissemination\/downloads_and_links\/Final_Report.html?nn=613800."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(94)00117-4"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00038-9"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.06.002"},{"key":"CIT0018","unstructured":"[BfR] Bundesinstitut f\u00fcr Risikobewertung [Federal Institute for Risk Assessment] (Germany). 2006. BfR recommends provisional daily upper intake level and a guidance value for morphine in poppy seeds. BfR Health Assessment No. 012\/2006, 27 Dec 2005. https:\/\/www.bfr.bund.de\/de\/a-z_index\/morphin-7391.html."},{"key":"CIT0019","unstructured":"[BfR] Bundesinstitut f\u00fcr Risikobewertung [Federal Institute for Risk Assessment] (Germany). 2018. Tetrahydrocannabinol levels are too high in many food products containing hemp \u2013 adverse health effects are possible, BfR Opinion no. 034\/2018 of 8 Nov 2018."},{"key":"CIT0020","unstructured":"[BfR] Bundesinstitut f\u00fcr Risikobewertung [Federal Institute for Risk Assessment] (Germany). 2021. The BfR recommends acute reference dose as basis for assessing hemp-containing foodstuff. BfR Opinion No 006\/2021 issued 17 Feb 2021."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4311"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.7.562"},{"key":"CIT0023","unstructured":"Bucher B, Gerlach K, Frei P, Kn\u00f6pfli K, Scheurer E. 2020. Bericht THC-Grenzwerte im Strassenverkehr \u2013 eine Literaturanalyse [Report THC limits in driving \u2013 a literature analysis], Institut f\u00fcr Rechtsmedizin der Universit\u00e4t Basel [Institute of Forensic Medicine], Dec 2020, Im Auftrag des Bundesamtes f\u00fcr Gesundheit (BAG) [Ordered by BAG]. German."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1007\/s10681-004-4811-6"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-893997-97-4.50011-5"},{"key":"CIT0026","unstructured":"Government of Canada. 2019. Dept of Justice. Legislative Background: reform to the Transportation Provisions of the Criminal Code (Bill C-46). Annex 2 \u2013 Drugs and Driving Committee report on drug per se limits. https:\/\/www.justice.gc.ca\/eng\/cj-jp\/sidl-rlcfa\/c46\/p8.html. [Date modified: 2019-08-30]."},{"key":"CIT0027","unstructured":"Government of Canada. 2021. Cannabis Regulations SOR\/2018-144. Part 6, 96(1). https:\/\/laws-lois.justice.gc.ca\/eng\/regulations\/SOR-2018-144\/page-15.html#docCont; (accessed 30 Jun 2021)."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90371-N"},{"key":"CIT0029","unstructured":"[DFG] Deutsche Forschungsgemeinschaft [German Research Foundation]. 1997\u20132004. \u03949-Tetrahydrocannabinol (THC) in Hanfprodukten [\u03949-Tetrahydrocannabinol (THC) in hemp foods]. Lebensmittel und Gesundheit II, Sammlung der Beschl\u00fcsse und Stellungnahmen [Food and Health II, Collection of Decisions and Opinions]. Mitt. 7, Kap. 25, p. 172 ff."},{"key":"CIT0030","unstructured":"[DFG] Deutsche Forschungsgemeinschaft [German Research Foundation] Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. 2020. List of MAK and BAT Values. https:\/\/www.dfg.de\/en\/dfg_profile\/statutory_bodies\/senate\/health_hazards\/."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi160"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1996.0116"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-4575(02)00153-7"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2004.05.015"},{"issue":"11","key":"CIT0035","first-page":"2405","volume":"9","author":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain).","year":"2011","journal-title":"EFSA J"},{"issue":"6","key":"CIT0036","first-page":"1","volume":"13","author":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain).","year":"2015","journal-title":"EFSA J"},{"issue":"4","key":"CIT0037","first-page":"4424:1","volume":"14","author":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain).","year":"2016","journal-title":"EFSA J"},{"issue":"5","key":"CIT0038","first-page":"5243:1","volume":"16","author":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain).","year":"2018","journal-title":"EFSA J"},{"key":"CIT0039","first-page":"5662:1","volume":"17","author":"EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain).","year":"2019","journal-title":"EFSA J"},{"issue":"5","key":"CIT0040","first-page":"1","volume":"13","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies).","year":"2015","journal-title":"EFSA J"},{"issue":"6","key":"CIT0041","first-page":"1150","volume":"7","author":"EFSA Sci Com (EFSA Scientific Committee).","year":"2009","journal-title":"EFSA J"},{"issue":"1","key":"CIT0042","first-page":"1","volume":"15","author":"EFSA Sci Com (EFSA Scientific Committee).","year":"2017","journal-title":"EFSA J"},{"issue":"1","key":"CIT0043","first-page":"1","volume":"18","author":"EFSA (European Food Safety Authority).","year":"2020","journal-title":"EFSA J"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0045","unstructured":"EIHA (European Industrial Hemp Association). Ba\u0148as B, Beitzke B, Carus M, Iffland K, Kruse D, Sarmento L, Sfrija D. 2017. Reasonable guidance values for THC (Tetrahydrocannabinol) in food products, Position Paper. https:\/\/eiha.org\/wp-content\/uploads\/2021\/01\/17-09-18-THC-Position-paper_EIHA.pdf."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112460109"},{"key":"CIT0047","unstructured":"EPA (Environmental Protection Agency (US)). Risk Assessment Forum. 2002. A Review of the Reference Dose and Reference Concentration Processes, EPA\/630\/P-02\/002F, Final Report. https:\/\/www.epa.gov\/risk\/review-reference-dose-and-reference-concentration-processes-document."},{"key":"CIT0048","unstructured":"EU Commission. 2020. Common Catalogue of varieties of agricultural plant species. 37th complete ed. (2019\/C13\/01). OCJ 13, 01.11.2019, p. 241-3. See also: EU. Plant variety database. A-85-Hemp-cannabis sativa L. https:\/\/ec.europa.eu\/food\/plant\/plant_propagation_material\/plant_variety_catalogues_databases\/search\/public\/index.cfm; (accessed 2021 Jul 02)."},{"key":"CIT0049","unstructured":"European Parliament and the Council. 2008. Regulation (EC) No. 1334\/2008 of the on flavourings and certain food ingredients with flavouring properties for use in and on foods, consolidated version 03.12.2020, Annex I, Table 1, FL no. 05.001. http:\/\/data.europa.eu\/eli\/reg\/2008\/1334\/2020-12-03."},{"key":"CIT0050","unstructured":"FDA (Food and Drug Administration (US)). 1985. NDA 018651. Review, 31.05.1985; https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=018651."},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0051","unstructured":"FDA (Food and Drug Administration (US)). 2017. Marinol\u00ae (dronabinol) capsules, for oral use, Prescribing Information, Revised 08\/2017, Reference ID: 4145204. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018651s029lbl.pdf."},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2016.01.007"},{"key":"CIT0054","unstructured":"FSANZ (Food Standards Australia New Zealand). 2011. Supporting Document 1, Risk Assessment Report, Application A360. https:\/\/www.foodstandards.govt.nz\/code\/applications\/Pages\/applicationa1039lowt4708.aspx."},{"key":"CIT0055","unstructured":"FSANZ (Food Standards Australia New Zealand). 2012. Application A1039 \u2013 Low THC Hemp as Food, Supporting Document 1 - Safety Assessment (Approval) \u2013 Application A1039. 8 Nov 2012. https:\/\/www.foodstandards.govt.nz\/code\/applications\/Pages\/applicationa1039lowt4708.aspx."},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.80"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2016.00688"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1021\/ja01062a046"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-017-1692-5"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-020-02380-3"},{"key":"CIT0061","unstructured":"Geiwitz J, the Ad Hoc Committee on Hemp Risks. 2001. THC in Hemp Foods and Cosmetics: The Appropriate Risk Assessment. www.hempreport.com\/response\/ResponseHCfinal2001.pdf."},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00538-2"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200608000-00010"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199201000-00018"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.06.011"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1300\/J175v03n01_02"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02009.x"},{"key":"CIT0068","volume-title":"Assessment of exposure to and human health risk from THC and Other Cannabinoids in Hemp Foods, Oct 11","author":"Grotenhermen F","year":"2001"},{"key":"CIT0069","unstructured":"Grotenhermen F, Leson G. 2002. Reassessing the Drug Potential of Industrial Hemp, nova-Institut, H\u00fcrth, Germany, and Leson Environmental Consulting, Berkeley, CA, 2002, pp. 2, 23. https:\/\/www.semanticscholar.org\/paper\/Reassessing-the-Drug-Potential-of-Industrial-Hemp-Grotenhermen-Leson\/79dbfcf834485087bfcc7b6e84e781ffeca32d3c."},{"key":"CIT0070","unstructured":"HAH (Hrvatska Agencija za Hranu. Radna grupa za dono\u0161enjeznanstvenog mi\u0161ljenja) [Croatian Food Agency Working Group on Scientific Opinion]. 2015. Znanstveno Mi\u0161ljenje, Znanstveno mi\u0161ljenjeo Utjecaju na zdravljerazli\u010ditih vrsta hrane od sjemenki koja sadr\u017eisjemenke industrijske konoplje (Zahtjev HAH-Z-2015-1) 25. svibnja 2015 [Scientific Opinion, Impact on the health of various types of seed foods containing industrial hemp seeds (REQUEST HAH-Z-2015-1) 25 May 2015 (English summary on p. 3\u20134)]. https:\/\/www.hah.hr\/doneseno-znanstveno-misljenje-hah-a-o-utjecaju-na-zdravlje-razlicitih-vrsta-hrane-od-sjemenki-i-koja-sadrzi-sjemenke-industrijske-konoplje\/; (accessed 16 Mar 2021)."},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.8268"},{"key":"CIT0072","unstructured":"Hargutt V, Kr\u00fcger H-P, Knoche A. 2011. DRUID: driving under the influence of alcohol, illicit drugs and medicines. Risk estimations from different methodological approaches. BASt\/UWURZ, 6th Framework Programme, DRUID Deliverable 1.3.1. https:\/\/www.bast.de\/Druid\/EN\/deliverales-list\/downloads\/Deliverable_1_3_1.html."},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.238287"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-020-02387-w"},{"key":"CIT0075","unstructured":"Health Belgium 2020. Positive List of Herbal product for smoking in Belgium. www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/positivelist_hps_002_14.pdf; (accessed 30 Jun 2021)."},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318200d727"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0708-19.2019"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790152"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1002\/ange.19300430405"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04164.x"},{"key":"CIT0082","unstructured":"Kruger C, Lodder R. 2018. Establishing limits for THC-content in hemp-derived foods, Food Technol. 72:20\u201321. https:\/\/www.ift.org\/news-and-publications\/food-technology-magazine\/issues\/2018\/september\/columns\/food-medicine-and-health-thc-content-in-hemp-derived-foods; (accessed 16 March 2021)."},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1038\/srep08126"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200204000-00010"},{"key":"CIT0085","unstructured":"Lehmann AJ, Fitzhugh OG. 1954. 100-Fold margin of safety. Assoc. Food and Drug Official US Q. Bulletin 18, 33-35. ISSN: 0004-5721. https:\/\/hero.epa.gov\/hero\/index.cfm\/reference\/details\/reference_id\/3195."},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/25.8.691"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/0273-2300(90)90030-F"},{"key":"CIT0088","unstructured":"Little Pro. 2017. https:\/\/www.chemsafetypro.com\/Topics\/CRA\/What_is_Point_of_Departure_(POD)_in_Toxicology_and_How_to_Use_It_to_Calculate_Reference_Dose_RfD.html."},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211812.27558.6e"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.026898"},{"key":"CIT0091","first-page":"15A","volume":"10","author":"McGilveray Pharmacon Inc and the University of Ottawa, Ontario.","year":"2005","journal-title":"Pain Res Managem"},{"key":"CIT0092","doi-asserted-by":"crossref","unstructured":"Mechoulam R, editor. 2005. Cannabinoids as Therapeutics, Birkh\u00e4user, Basel.","DOI":"10.1007\/3-7643-7358-X"},{"key":"CIT0093","unstructured":"M\u00fctze F. 2017. The drug driving situation in the Netherlands: regulating drug driving to protect all road users, https:\/\/etsc.eu\/17-november-2017-regulating-drug-driving-to-protect-all-road-users-vienna\/."},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/29.8.782"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00130"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70137-1"},{"key":"CIT0097","unstructured":"NIH. 1996. National Toxicology Program: Technical Report on the toxicology and carcinogenesis of 1-trans-delta-9-tetrahydrocannabinol (CAS NO. 1972-08-3) in F344\/N rats and B6C3F1 mice (gavage studies). National Toxicology Program Technical Report 446, NIH Publication No. 97-3362. https:\/\/pubmed.ncbi.nlm.nih.gov\/12594529\/."},{"key":"CIT0098","unstructured":"Nova-Institut. 1997. Survery commissioned by Hanfgesellschaft (Berlin) for information of the European Commission. H\u00fcrth (Germany). https:\/\/eiha.org\/documents\/hanfgesellschaft-01-12-1997\/."},{"key":"CIT0099","unstructured":"OECD. 2003. Descriptions of Selected Key Generic Terms Used in Chemical Hazard\/Risk Assessment, ENV\/JM\/MONO (2003) 15, OECD Series on Testing and Assessment, No. 44. 13 p. http:\/\/www.oecd.org\/officialdocuments\/displaydocumentpdf\/?cote=ENV\/JM\/MONO(2003)15&doclanguage=en; (accessed 16 Mar 2021)."},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-9990-z"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832ba850"},{"issue":"2","key":"CIT0102","first-page":"32","volume":"1","author":"Pate DW.","year":"1994","journal-title":"J Intl Hemp Assoc"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2516-3"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02621.x"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.120537"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90385-F"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56060309"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001089"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.015"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1997.1195"},{"key":"CIT0112","volume-title":"\u03949-Tetrahydrocannabinols\u00e4ure A \u2013 Studien und Untersuchungen zur Anwendung als Cannabis-Konsummarker in der forensischen Toxikologie [\u03949-Tetrahydrocannabinolic acid A \u2013 studies and investigations for an application as a cannabis consumption marker in forensic toxicology]","author":"Roth NB.","year":"2014"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790144"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.213"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617717001102"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.09.025"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1578366"},{"issue":"4","key":"CIT0118","first-page":"149","volume":"7","author":"Sharma P","year":"2012","journal-title":"Iran J Psychiatry"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107621"},{"key":"CIT0120","volume-title":"Limit and guideline values for THC (tetrahydrocannabinol) in hemp foods, nova Institut f\u00fcr \u00d6kologie und Innovation","author":"Skoczinski P","year":"2019"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.3109\/03602532.2013.849268"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1847"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700701"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(73)90310-4"},{"key":"CIT0125","unstructured":"T\u00f6nnes S, Auw\u00e4rter V, Knoche A, Skopp G. 2016. Stand der wissenschaftlichen Erkenntnisse zur Feststellung einer mangelhaften Trennung von Cannabiskonsum und Fahren anhand der Konzentration von Tetrahydrocannabinol [Scientific evaluation on the ability to separate driving from cannabis consumption on the basis of tetrahydrocannabinol (THC) concentrations in blood serum]. Blutalkohol [Alcohol, Drugs, Behavior and Traffic Safety]. 53:409\u2013414. German, English summary. https:\/\/www.bads.de\/wissen\/fachzeitschrift-blutalkohol\/archiv-2002-2016\/."},{"key":"CIT0126","unstructured":"Unimed Pharmaceuticals Inc. 2004. Marinol\u00ae (Dronabinol) Capsules, NDA 18-651\/S-021, 500012 Rev Sep 2004."},{"key":"CIT0127","unstructured":"US Public Health Service, Dept of Health & Human Services (HHS). 2018. Letter to the DEA. Basis for the recommendation to place cannabidiol in Schedule V of the Controlled Substances Act, Chapter \u201cHuman Potential Abuse Study (Study #GWEP1431)\u201d p. 9\u201313. See also: https:\/\/hempindustrydaily.com\/fda-cbd-shouldnt-be-a-controlled-substance-but-treaties-require-it\/."},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkx012"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02594.x"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.12.032"},{"key":"CIT0131","unstructured":"WHO (World Health Organization), Expert Committee on Drug Dependence (ECDD). 2018. Critical Review, Delta-9-tetrahydrocannabinol. Section 3: Toxicology. https:\/\/www.who.int\/medicines\/access\/controlled-substances\/THCv1.pdf."},{"key":"CIT0132","unstructured":"WHO (World Health Organization), Joint FAO\/WHO Expert Committee on Food Additives (JECFA). 2012. Food Additive Series: 65, Safety evaluation of certain food additives and contaminants\/prepared by the Seventy-fourth meeting of the JECFA, p. 308."},{"key":"CIT0133","unstructured":"WHO (World Health Organization), Joint FAO\/WHO Expert Committee on Food Additives (JECFA). 2017. Guidance document for the establishment of Acute Reference Dose (ARfD) for veterinary drug residues in food. Geneva. ISBN 978-92-4-151262-6."},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1973.tb09132.x"},{"key":"CIT0135","unstructured":"Wikipedia. 2021. https:\/\/en.wikipedia.org\/wiki\/Cannabidiol; (accessed 16 Mar 2021)."},{"key":"CIT0136","unstructured":"Wikipedia. 2021a. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Uruguay; (accessed 16 Mar 2021)."},{"key":"CIT0137","unstructured":"Wikipedia. 2021b. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_the_United_States; (accessed 16 Mar 2021)."},{"key":"CIT0138","unstructured":"Wikipedia. 2021c. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Luxembourg; (accessed 16 Mar 2021)."},{"key":"CIT0139","unstructured":"Wikipedia. 2021d. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_the_Netherlands; (accessed 16 Mar 2021)."},{"key":"CIT0140","unstructured":"Wikipedia. 2021e. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Spain; (accessed 16 Mar 2021)."},{"key":"CIT0141","unstructured":"Wikipedia. 2021f. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Portugal; (accessed 16 Mar 2021)."},{"key":"CIT0142","unstructured":"Wikipedia. 2021g. https:\/\/en.wikipedia.org\/wiki\/CannabisinAustria. (Accessed 16 March 2021)."},{"key":"CIT0143","unstructured":"Wikipedia. 2021h. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Switzerland; (accessed 16 Mar 2021)."},{"key":"CIT0144","unstructured":"Wikipedia. 2021i. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_France; (accessed 16 Mar 2021)."},{"key":"CIT0145","unstructured":"Wikipedia. 2021j. https:\/\/en.wikipedia.org\/wiki\/Cannabis_in_Sweden; (accessed 16 Mar 2021)."},{"key":"CIT0146","unstructured":"Williams P. 2020. https:\/\/www.hempgrower.com\/article\/european-parliament-votes-bring-hemp-thc-back-down-lower-percent\/."},{"key":"CIT0147","unstructured":"Wohlfarth A. 2012. Pharmakokinetik und Metabolismus von \u03949-Tetrahydrocannabinols\u00e4ure A (THCA) im Menschen [Pharmacokinetics and metabolism of \u03949-Tetrahydrocannabinolic acid A (THCA) in Humans]. Dissertation. URN: urn:nbn:de:bsz:25-opus-85046. German. Abstract English: https:\/\/freidok.uni-freiburg.de\/data\/8504."},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146467"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.02.017"},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(99)01287-X"},{"key":"CIT0151","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2495-x"},{"key":"CIT0152","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432554"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03329.x"}],"container-title":["Critical Reviews in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408444.2021.2008867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T18:32:04Z","timestamp":1646332324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408444.2021.2008867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":152,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,9,14]]}},"alternative-id":["10.1080\/10408444.2021.2008867"],"URL":"https:\/\/doi.org\/10.1080\/10408444.2021.2008867","relation":{},"ISSN":["1040-8444","1547-6898"],"issn-type":[{"value":"1040-8444","type":"print"},{"value":"1547-6898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}